Key Takeaways From ANNEXA-I Study
Dr Connolly highlights the cautious patient selection and the significance of reducing hematoma expansion for improved outcomes in cases of intracerebral hemorrhage (ICH) associated with the use of a reversal agent for factor Xa inhibitors.
Stuartj Connolly Hematoma Expansion Intracerebral Hemorrhage Direct Oral Anticoagulant Annexai Study Hemostatic Efficacy
Source: ajmc.com